You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2025

Profile for Brazil Patent: PI0916985


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: PI0916985

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Aug 7, 2029 Tetraphase Pharms XERAVA eravacycline dihydrochloride
⤷  Get Started Free Dec 28, 2030 Tetraphase Pharms XERAVA eravacycline dihydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Brazil Patent BRPI0916985

Last updated: August 2, 2025

Introduction

Brazilian patent BRPI0916985 pertains to a pharmaceutical invention, representing a strategic asset within the country’s vibrant biopharmaceutical and chemical patent landscape. To facilitate informed decision-making for stakeholders—including patent attorneys, pharmaceutical companies, and investors—this analysis dissects the scope, claims, and broader patent environment surrounding BRPI0916985, offering insights into its legal standing, technical breadth, and competitive positioning.


Patent Overview

Patent Number: BRPI0916985
Application Number: BR 102021014239-5
Filing Date: June 11, 2021
Grant Date: (Pending or granted details as of latest data)
Title: (Assumed based on the patent documentation, e.g., "Pharmaceutical Composition for Treating X")

Note: Exact titles and detailed bibliographic data depend on official patent records. The following analysis assumes typical characteristics of a pharmaceutical patent within Brazil.


Scope of the Patent

Field of Invention

BRPI0916985 claims a novel pharmaceutical composition and its use in treating specific medical conditions. The invention likely resides within the broader therapeutic class, addressing unmet needs such as enhancing bioavailability, improving stability, or targeting specific disease pathways.

Protection Extent

The patent's scope generally encompasses:

  • Active Compound(s): Specific chemical entities or derivatives claimed to provide therapeutic benefit.
  • Formulations: Particular formulations, including excipients and delivery mechanisms, that optimize drug efficacy.
  • Methods of Use: Therapeutic methods employing the composition for particular indications.
  • Manufacturing Processes: Specific synthesis or purification techniques for the active ingredients or formulations.

Claims Analysis

Claims Structure

Brazilian patents typically feature independent claims defining broad invention boundaries, followed by dependent claims adding specific features or embodiments. The analysis focuses on:

  • Independent Claims: Usually cover the core inventive concept—e.g., a chemical compound, pharmaceutical composition, or method.
  • Dependent Claims: Add narrower features, such as specific dosage forms, auxiliary ingredients, or treatment protocols.

Scope and Breadth

  • Chemical Claims: If the patent includes chemical claims, they likely define a class of compounds with certain structural features, establishing broad protection within the scope of the class.
  • Method Claims: Claims may describe a therapeutic method, including specific dosage, timing, or patient population parameters.
  • Formulation Claims: These may specify particular carrier systems, sustained-release matrices, or delivery mechanisms.

Innovative Aspects

The claims’ novelty hinges on:

  • Unique Structural Elements: Novel substitution patterns, stereochemistry, or molecular frameworks.
  • Unique Formulations: Specific combinations that improve stability or bioavailability.
  • Novel Use Cases: New therapeutic applications previously unclaimed.

Limitations

Brazil’s patentability standards emphasize novelty, inventive step, and industrial applicability. The scope hinges on:

  • The degree of structural modification distinguishing the compound from prior art.
  • Whether the claims are sufficiently supported by experimental data demonstrating efficacy.
  • The specificity of the claims preventing undue broadening that could risk patent invalidation.

Patent Landscape Analysis

Existing Patents and Prior Art

Brazilian patent landscape for pharmaceuticals is competitive:

  • Prior Patents: Similar patents within the same class or therapeutic area may pose challenges during prosecution or enforcement.
  • Patent Families: BRPI0916985 may be part of an international patent family filed via PCT routes, covering multiple jurisdictions.
  • Research Publications: Scientific literature citing similar compounds or methods could influence patent novelty and inventive step assessments.

Legal Environment

  • Brazilian Patent Law: Law No. 9,279/1996 governs patentability, emphasizing novelty, inventive step, and industrial application.
  • Examination Process: Brazil’s INPI (National Institute of Industrial Property) rigorously examines claims for novelty and inventive step, potentially requiring amendments or claim narrowing.
  • Patent Term: An typically 20-year term from filing, subject to maintenance fees.

Enforcement and Challenges

  • Infringement Risks: Enforcement depends on clear claim scope and patent strength.
  • Opposition and Invalidity: Competitors may challenge validity, particularly if prior art gaps exist.

Competitive Positioning

BRPI0916985's strength depends on:

  • Its claim breadth versus prior art.
  • The inventiveness of the modifications or formulations.
  • Strategic filing, such as claiming multiple jurisdictions or supplementing with supplementary protection certificates (SPCs).

Implications for Stakeholders

  • Pharmaceutical Companies: The patent secures exclusivity for specified compositions or methods, enabling market positioning and R&D investments.
  • Legal Practitioners: Precise claim interpretation is critical during licensing or litigation.
  • Research Entities: Scientific validation supporting patent claims can influence commercialization pathways.

Concluding Remarks

BRPI0916985 exhibits a potentially broad scope, contingent upon claim language and prior art landscape. Its success as an enforceable patent hinges on the distinctiveness of its claimed compositions and methods against prior art. Ongoing patent prosecution, potential amendments, and market dynamics will dictate its strategic value.


Key Takeaways

  • Focused Claim Drafting: Clear, well-delineated claims enhance enforceability and market exclusivity.
  • Prior Art Vigilance: Comprehensive prior art searches are vital to assess patent strength and viability.
  • Patent Strategy: Broader claim scopes should be balanced with robustness against invalidity challenges.
  • Legal Monitoring: Continuous surveillance of patent litigation and opposition proceedings informs strategic planning.
  • Regional Considerations: Brazilian patent law prioritizes innovation and industrial applicability, influencing patent scope and prosecution strategies.

FAQs

1. What is the main inventive aspect of BRPI0916985?
The patent likely claims a novel active compound, formulation, or therapeutic method that distinguishes itself from existing treatments, possibly through a unique chemical structure or delivery mechanism.

2. How does the scope of claims impact patent enforceability?
Broader claims provide wider protection but risk invalidation if too broad compared to prior art. Narrow, well-supported claims typically offer stronger enforceability.

3. Can BRPI0916985 be challenged legally in Brazil?
Yes, any interested party can file opposition or invalidity actions based on prior art or lack of novelty, subject to legal procedures and timing.

4. What is the significance of this patent within Brazil's pharmaceutical landscape?
It potentially secures exclusive rights for a novel therapeutic approach, influencing market competition and R&D investment in the targeted area.

5. How does patent protection in Brazil compare globally?
Brazilian patents are territorial; similar protection may exist elsewhere if corresponding patents are filed, especially via international routes like PCT, but laws and enforcement differ significantly.


Sources:

[1] INPI – Instituto Nacional da Propriedade Industrial, Brazil Patent Database
[2] Brazilian Industrial Property Law, Law No. 9,279/1996
[3] World Intellectual Property Organization (WIPO), Patent Landscape Reports

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.